Clinical Trial Update: Genetically Modified T Cells Against Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating genetically modified T cells for ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Genetically Modified T Cells

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING